Olumiant Drug Interactions: 249 Major, 180 Moderate
Olumiant (Baricitinib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Olumiant. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Baricitinib.
Level 2 evidence
Abemaciclib
The excretion of Baricitinib can be decreased when combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Baricitinib.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Acalabrutinib is combined with Baricitinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Baricitinib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Baricitinib.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Baricitinib.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Baricitinib.
Level 2 evidence
Acetaminophen
The risk or severity of liver damage can be increased when Acetaminophen is combined with Baricitinib.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Acetazolamide is combined with Baricitinib.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Baricitinib.
Level 2 evidence
Acetylsalicylic acid
The serum concentration of Baricitinib can be increased when it is combined with Acetylsalicylic acid.
Level 1 evidence
Enter your NPI to unlock 19 major interactions for Olumiant
Olumiant (Baricitinib) has 826 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Olumiant (Baricitinib) has 249 major, 180 moderate, and 397 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Olumiant. Always confirm against the full prescribing information.